Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

Xiao-sheng Hao,Jiang-tao Wang,Chen Chen,Yun-peng Hao,Jian-min Liang,Song-yan Liu

DOI: https://doi.org/10.3389/fneur.2023.1178132

IF: 3.4

2023-03-14

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2020.584446.].

neurosciences,clinical neurology

What problem does this paper attempt to address?

Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Jiajia Li,Yupeng Jiang,Qin Dai,Yue Yu,Xin Lv,Yan Zhang,Xiaohua Liao,Liyun Ao,Gaoyun Hu,Jie Meng,Zhangzhe Peng,Lijian Tao,Yanyun Xie

DOI: https://doi.org/10.3389/fphar.2023.1188615

IF: 5.6

2023-04-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1043945.].

pharmacology & pharmacy
Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases

Xiao-sheng Hao,Jiang-tao Wang,Chen Chen,Yun-peng Hao,Jian-min Liang,Song-yan Liu

DOI: https://doi.org/10.3389/fneur.2020.584446

IF: 3.4

2020-11-09

Frontiers in Neurology

Abstract:Objective: To explore the effectiveness and safety of mycophenolate mofetil (MMF) as a second-line medication in the treatment of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, the most common and severe autoimmune encephalitis.Methods: The clinical data of six children with anti-NMDAR encephalitis admitted to the First Hospital of Jilin University were retrospectively analyzed, and the effectiveness and safety of MMF were evaluated.Results: Six children with anti-NMDAR encephalitis were treated with MMF in the 2nd or 3rd treatment disease event (3 cases vs. 3 cases). MMF initiation was mean 19.2 months (range 6–39 months) after disease onset at a mean dose of 25.6 mg/kg (range 19.6–28.4 mg/kg) for 14 months (range 6–26 months). Only two patients had transient mild diarrhea within 2 weeks of MMF application. During follow-up, one patient relapsed whilst on MMF, one patient discontinued MMF, and 4 cases were still on MMF.Conclusion: The use of MMF in anti-NMDAR encephalitis may be effective and safe. MMF can be used as one of the relapse prevention options in patients who already have relapsed or possibly even after the first event. Delayed use may be the main reason for MMF failure.

neurosciences,clinical neurology
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy

Jia-Qin Yi,Sheng Huang,Miao-Juan Wu,Jie-Hui Ma,Li-Juan Huang,Song Liang,Dan Sun

DOI: https://doi.org/10.3389/fphar.2023.1295784

IF: 5.6

2023-09-30

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1189058.].

pharmacology & pharmacy
Corrigendum: Low Frequency Ultrasound with Injection of NMO-IgG and Complement Produces Lesions Different from Experimental Autoimmune Encephalomyelitis Mice

Weiwei Xiang,Chong Xie,Jiaying Luo,Wei Zhang,Xinxin Zhao,Hong Yang,Yu Cai,Jie Ding,Yishu Wang,Yong Hao,Ying Zhang,Yangtai Guan

DOI: https://doi.org/10.3389/fimmu.2022.842300

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.727750.].
Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway

Xueming Zhou,Chenyue Liu,Yueyun Liu,Qingyu Ma,Xin Zhao,Youming Jiang,Xiaojuan Li,Jia-Xu Chen

DOI: https://doi.org/10.3389/fphar.2022.1042762

IF: 5.6

2022-12-16

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.586788.].

pharmacology & pharmacy
Corrigendum to "Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats"

Wenli Yu,Jingshu Lyu,Lili Jia,Mingwei Sheng,Hongli Yu,Hongyin Du

DOI: https://doi.org/10.1155/2021/9797165

2021-08-04

Abstract:[This corrects the article DOI: 10.1155/2020/7385458.].
Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Quanfeng Zhao,Pan Ma,Peishu Fu,Jiayu Wang,Kejing Wang,Lin Chen,Yang Yang

DOI: https://doi.org/10.3389/fphar.2022.990048

IF: 5.6

2022-08-11

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.912256.].

pharmacology & pharmacy
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Huimin Yan,Jia Lu,Jiabao Wang,Lu Chen,Yu Wang,Lin Li,Lin Miao,Han Zhang

DOI: https://doi.org/10.3389/fphar.2021.808424

IF: 5.6

2022-01-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.730567.].

pharmacology & pharmacy
Corrigendum: Analysis of 14 Patients With Congenital Nephrotic Syndrome.

Yan Chen,Yanqin Zhang,Fang Wang,Hongwen Zhang,Xuhui Zhong,Huijie Xiao,Yong Yao,Yi Jiang,Jie Ding,Xinlin Hou

DOI: https://doi.org/10.3389/fped.2019.00341

IF: 3.569

2019-01-01

Frontiers in Pediatrics

Abstract:[This corrects the article DOI: 10.3389/fped.2019.00341.].
Corrigendum: Dual NDP52 Function in Persistent CSFV Infection

Shuangqi Fan,Keke Wu,Chaowei Luo,Xin Li,Mengpo Zhao,Dan Song,Shengming Ma,Erpeng Zhu,Yuming Chen,Hongxing Ding,Lin Yi,Jun Li,Mingqiu Zhao,Jinding Chen

DOI: https://doi.org/10.3389/fmicb.2021.673468

IF: 5.2

2021-04-12

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2019.02962.].

microbiology
Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Song Miao,Jie Lü,Weiqi Dai,Wei Fan,Ling Xu,Kan Chen,Lei He,Ping Cheng,Yan Zhang,Chengfen Wang,Dong Wu,Jing Yang,Rong Zhu,Huawei Zhang,Yingqun Zhou,Chuanyong Guo

DOI: https://doi.org/10.1155/2016/5434275

2016-01-01

Mediators of Inflammation

Abstract:[This corrects the article DOI: 10.1155/2013/461536.].
Corrigendum: Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Shuai Zhang,Shanshan Zhang,Wenqing Gong,Guopei Zhu,Songtao Wang,Yalin Wang,Michael Halim,Kaidi Wang,Guomin Zhou,Qiong Liu

DOI: https://doi.org/10.3389/fnins.2020.606486

IF: 4.3

2020-10-22

Frontiers in Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnins.2018.00890.].

neurosciences
Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Yang Han,Chunhong Gao,Hao Wang,Jiejie Sun,Meng Liang,Ye Feng,Qianqian Liu,Shiyao Fu,Lin Cui,Chunsheng Gao,Yi Li,Yang Yang,Baoshan Sun

DOI: https://doi.org/10.1016/j.bioactmat.2021.06.002

IF: 18.9

2022-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.08.017.].

engineering, biomedical,materials science, biomaterials
Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Yajing Chen,Tingting Wu,Heng Li,Xuan Li,Qing Li,Xiaoying Zhu,Mei Yu,Sheng-Han Kuo,Fang Huang,Yun-Cheng Wu

DOI: https://doi.org/10.3389/fnagi.2021.620015

IF: 4.8

2021-07-06

Frontiers in Aging Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnagi.2019.00044.].

neurosciences,geriatrics & gerontology,gerontology
Corrigendum to “Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models” [J Ginseng Res 46 (2022) 426-434]

Genmeng Yang,Juan Li,Yanxia Peng,Baoyu Shen,Yuanyuan Li,Liu Liu,Chan Wang,Yue Xu,Shucheng Lin,Shuwei Zhang,Yi Tan,Huijie Zhang,Xiaofeng Zeng,Qi Li,Gang Lu

DOI: https://doi.org/10.1016/j.jgr.2023.01.001

IF: 5.735

2023-03-01

Journal of Ginseng Research

Abstract:[This corrects the article DOI: 10.1016/j.jgr.2021.07.005.].

chemistry, medicinal,integrative & complementary medicine
Corrigendum: Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family

Di Zhang,Yi Qu,Xue-Qi Dong,Yi-Ting Lu,Kun-Qi Yang,Xin-Chang Liu,Peng Fan,Yu-Xiao Hu,Chun-Xue Yang,Ling-Gen Gao,Ya-Xin Liu,Xian-Liang Zhou

DOI: https://doi.org/10.3389/fped.2022.961964

IF: 3.569

2022-06-30

Frontiers in Pediatrics

Abstract:[This corrects the article DOI: 10.3389/fped.2022.887214.].

pediatrics
Corrigendum: Vi4-miR-185-5p-Igfbp3 Network Protects the Brain From Neonatal Hypoxic Ischemic Injury via Promoting Neuron Survival and Suppressing the Cell Apoptosis

Liu-Lin Xiong,Lu-Lu Xue,Ruo-Lan Du,Hao-Li Zhou,Ya-Xin Tan,Zheng Ma,Yuan Jin,Zi-Bin Zhang,Yang Xu,Qiao Hu,Larisa Bobrovskaya,Xin-Fu Zhou,Jia Liu,Ting-Hua Wang

DOI: https://doi.org/10.3389/fcell.2022.852539

IF: 5.5

2022-02-16

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.529544.].

cell biology,developmental biology
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Siddhi N Paudel,Brian J Hutzen,Katherine E Miller,Elizabeth A R Garfinkle,Chun-Yu Chen,Pin-Yi Wang,Andrea M Glaspell,Mark A Currier,Emily M Ringwalt,Louis Boon,Elaine R Mardis,Mitchell S Cairo,Nancy Ratner,Rebecca D Dodd,Kevin A Cassady,Timothy P Cripe

DOI: https://doi.org/10.3389/fimmu.2024.1456897

2024-07-09

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1384623.].
Corrigendum to “3-(1H-benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-Oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells Against Oxidative Stress Via ERK1/2 Phosphorylation”

Li-li Xu,Tian Liu,Lei Wang,Li,Yu-feng Wu,Cui-cui Li,Bin Di,Q. You,Zhengyu Jiang

DOI: https://doi.org/10.1155/2018/8780453

2018-01-01

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2018/3271617.].

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy

Corrigendum: Low Frequency Ultrasound with Injection of NMO-IgG and Complement Produces Lesions Different from Experimental Autoimmune Encephalomyelitis Mice

Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway

Corrigendum to "Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats"

Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Corrigendum: Analysis of 14 Patients With Congenital Nephrotic Syndrome.

Corrigendum: Dual NDP52 Function in Persistent CSFV Infection

Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Corrigendum: Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Corrigendum to “Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models” [J Ginseng Res 46 (2022) 426-434]

Corrigendum: Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family

Corrigendum: Vi4-miR-185-5p-Igfbp3 Network Protects the Brain From Neonatal Hypoxic Ischemic Injury via Promoting Neuron Survival and Suppressing the Cell Apoptosis

Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Corrigendum to “3-(1H-benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-Oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells Against Oxidative Stress Via ERK1/2 Phosphorylation”

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]